Skip to main content
. 2021 Jan 16;13(1):13–23. doi: 10.4253/wjge.v13.i1.13

Table 3.

Incremental Cost Effectiveness Ratio analysis

Efficacy outcome
ICER analysis
Early rebleeding (n of events) (USD 3048.50) - (USD 11060.90)/(0) - (3) = US$ 2670.80
Adverse events (n of events) (USD 3048.50) - (USD 11060.90)/(2) - (3) = US$ 8012.40
Length of hospitalization (total days) (USD 3048.50) - (USD 11060.90)/(1) - (64) = US$ 127.18
6-mo mortality (n of events) (USD 3048.50) - (USD 11060.90)/(0) - (1) = US$ 8012.40

ICER: Incremental Cost-Effectiveness Ratio; USD: United States of America dollar.